OVERVIEW

The Biomarker and Companion Diagnostics Virtual Conference is organized by MarketsandMarkets (MNM) Research Private Ltd. and will be held from Oct 20 - 23, 2020 would address the gaps between early stage biomarker development and the commercialization stage of biomarkers.

Description:
The emergence of the need for safety and efficacy of a drug subjected to individual patients has made companion diagnostics one of the most sought after topics in the field of In-Vitro Diagnostics. The surge of investment in companion diagnostics has brought forward issues regarding regulations and their intricacies and boosted new trends in immuno-oncology, immuno-therapies, data interpretation and unconventional design of clinical trials.

This conference would also highlight case studies on leveraging emerging technologies in Digital Biomarkers, Precision Medicine and Big Data.

Regarding commercialization of biomarkers, leading industry and academic experts would share their case studies focusing on advancements in companion diagnostics area. The keynote presentations would also help the attendees understand the issues related to clinical translation of biomarkers.

Key Highlights:
• Commercialization of CDx
• Proteomics and Genomics based Biomarkers
• Biomarker Drug Discovery and Assay Development
• Multiplex Companion Diagnostics and Regulatory Guidelines
• Design of clinical trials in CDx
• Digital Biomarkers, Predictive Biomarkers, Precision Medicine and Big Data
• Clinical Applications of Biomarkers in Immuno-Oncology, Neurology and Inflammatory Diseases